Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study

JAMA Network Open 2026 Open access

Read full text
Authors: Nicolò Bizzarri, Zoltán Novàk, Giulio Ricotta, Mihai Emil Căpîlna, Diana Giannarelli, Santiago Domingo, Vito Chiantera, Hüseyin Akıllı, David Cibula, Diana Zach, Andrea Miranda, Porfyrios Korompelis
+29 more Enrique Chacón, Ignacio Zapardiel, Björn Lampe, Valentyn Svintsitskyi, Olga Matylevich, Gabriëlle H. van Ramshorst, Cagatay Taskiran, Fuat Demirkıran, Tibor Lengyel, Giuseppe Vizzielli, Matteo Loverro, Francesco Fanfani, Cláudia Marchetti, Gwénaël Ferron, Alexandre Martinez, Élodie Gauroy, Emmanuel Ladanyi, Leo Szilard Kiss, Victor Lago, Manel Montesinos-Albert, Mariano Catello Di Donna, Giuseppe Cucinella, Jiri Sláma, Viktória Rosta, Mustafa Zelal Muallem, Ali Kucukmetin, Anna Fagotti, Sahar Salehi, Denis Querleu
DOI: 10.1001/jamanetworkopen.2026.20335
Cited by: 1
References: 6

Abstract

This comparative effectiveness research study investigates whether adjuvant chemotherapy is associated with survival in patients with gynecologic cancer undergoing pelvic exenteration with pelvic lymph node metastasis.

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Colorectal Cancer Surgical Treatments Ovarian cancer diagnosis and treatment

Publication details

Journal / source
JAMA Network Open
Publisher
American Medical Association (AMA)
Volume
9
Issue
6
Pages
e2620335–e2620335
Publication date
26 June 2026
Language
EN